EMD-4398

Single-particle
4.24 Å
EMD-4398 Deposition: 02/05/2018
Map released: 06/03/2019
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-4398

Cryo-EM structure of BK polyomavirus like particle in complex with single chain antibody ScFv41F17

EMD-4398

Single-particle
4.24 Å
EMD-4398 Deposition: 02/05/2018
Map released: 06/03/2019
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens, BK polyomavirus
Sample: BK polyomavirus like particle in complex with single chain antibody ScFv41F17
Fitted models: 6gg0 (Avg. Q-score: 0.419)

Deposition Authors: Srinivas H
Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC Polyomaviruses.
PUBMED: 30824324
DOI: doi:10.1016/j.immuni.2019.02.003
ISSN: 1074-7613
ASTM: IUNIEH
Abstract:
Human polyomaviruses cause a common childhood infection worldwide and typically elicit a neutralizing antibody and cellular immune response, while establishing a dormant infection in the kidney with minimal clinical manifestations. However, viral reactivation can cause severe pathology in immunocompromised individuals. We developed a high-throughput, functional antibody screen to examine the humoral response to BK polyomavirus. This approach enabled the isolation of antibodies from all peripheral B cell subsets and revealed the anti-BK virus antibody repertoire as clonally complex with respect to immunoglobulin sequences and isotypes (both IgM and IgG), including a high frequency of monoclonal antibodies that broadly neutralize BK virus subtypes and the related JC polyomavirus. Cryo-electron microscopy of a broadly neutralizing IgG single-chain variable fragment complexed with BK virus-like particles revealed the quaternary nature of a conserved viral epitope at the junction between capsid pentamers. These features unravel a potent modality for inhibiting polyomavirus infection in kidney transplant recipients and other immunocompromised patients.